Amir H. Lebastchi

Assistant Professor of Clinical Urology

Image of Amir H. Lebastchi
Is this your profile? Click to edit

Publications

  • Utilization of focal therapy for patients discontinuing active surveillance of prostate cancer: Recommendations of an international Delphi consensusUrol Oncol. 2021 11; 39(11):781. e17-781. e24. . View in PubMed
  • Risk of adverse pathology at prostatectomy in the era of MRI and targeted biopsies; rethinking active surveillance for intermediate risk prostate cancer patientsUrol Oncol. 2021 10; 39(10):729. e1-729. e6. . View in PubMed
  • Timing, incidence and management of delayed bleeding after partial nephrectomy in patients at risk for recurrent, bilateral, multifocal renal tumorsUrol Oncol. 2024 Jul; 42(7):222. e1-222. e7. . View in PubMed
  • Patient-reported Satisfaction and Regret Following Focal Therapy for Prostate Cancer: A Prospective Multicenter Evaluation Eur Urol Open Sci. 2023 Apr; 50:10-16. . View in PubMed
  • Primary Whole-gland Ablation for the Treatment of Clinically Localized Prostate Cancer: A Focal Therapy Society Best Practice Statement Eur Urol. 2023 12; 84(6):547-560. . View in PubMed
  • Transperineal magnetic resonance imaging/transrectal ultrasonography fusion prostate biopsy under local anaesthesia: the ‘double-freehand’ technique BJU Int. 2023 06; 131(6):770-774. . View in PubMed
  • Transperineal vs transrectal magnetic resonance and ultrasound image fusion prostate biopsy: a pair-matched comparison Sci Rep. 2023 08 18; 13(1):13457. . View in PubMed
  • An Assessment Tool to Provide Targeted Feedback to Robotic Surgical Trainees: Development and Validation of the End-To-End Assessment of Suturing Expertise (EASE) Urol Pract. 2022 Nov; 9(6):532-539. . View in PubMed
  • Reply by Authors Urol Pract. 2022 Nov; 9(6):541. . View in PubMed
  • Molecular biomarkers in the context of focal therapy for prostate cancer: recommendations of a Delphi Consensus from the Focal Therapy Society Minerva Urol Nephrol. 2022 10; 74(5):581-589. . View in PubMed
  • Using Prostate Imaging-Reporting and Data System (PI-RADS) Scores to Select an Optimal Prostate Biopsy Method: A Secondary Analysis of the Trio Study Eur Urol Oncol. 2022 04; 5(2):176-186. . View in PubMed
  • Focal Therapy for Prostate Cancer: Getting Ready for Prime Time Eur Urol. 2022 01; 81(1):34-36. . View in PubMed
  • Multiparametric ultrasound of prostate: role in prostate cancer diagnosis Ther Adv Urol. 2022 Jan-Dec; 14:17562872221145625. . View in PubMed
  • The Intraoperative Complications Assessment and Reporting with Universal Standards (ICARUS) Global Surgical Collaboration Project: Development of Criteria for Reporting Adverse Events During Surgical Procedures and Evaluating Their Impact on the Postoperative Course Eur Urol Focus. 2022 02 14. . View in PubMed
  • Future perspective of focal therapy for localized prostate cancer Asian J Urol. 2021 Oct; 8(4):354-361. . View in PubMed
  • Focal Therapy for Low-Risk Prostate Cancer Opinion: No J Endourol. 2021 Sep; 35(9):1284-1287. . View in PubMed
  • MRI-guided focal laser ablation of prostate cancer: a prospective single-arm, single-center trial with 3 years of follow-up Diagn Interv Radiol. 2021 May; 27(3):394-400. . View in PubMed
  • Techniques and Outcomes of MRI-TRUS Fusion Prostate Biopsy Curr Urol Rep. 2021 Mar 22; 22(4):27. . View in PubMed
  • Comparative Effectiveness of Techniques in Targeted Prostate Biopsy Cancers (Basel). 2021 Mar 22; 13(6). . View in PubMed
  • Role of MRI for the detection of prostate cancer World J Urol. 2021 Mar; 39(3):637-649. . View in PubMed
  • Role of multiparametric prostate MRI in the management of prostate cancer World J Urol. 2021 Mar; 39(3):651-659. . View in PubMed
  • Making a case “for” focal therapy of the prostate in intermediate risk prostate cancer: current perspective and ongoing trials World J Urol. 2021 Mar; 39(3):729-739. . View in PubMed
  • Comment on: “Fusion US/MRI prostate biopsy using a computer aided diagnostic (CAD) system” Minerva Urol Nephrol. 2021 10; 73(5):686-688. . View in PubMed
  • X-Capsular Incision for Tumor Enucleation (X-CITE)-Technique: A Method to Maximize Renal Parenchymal Preservation for Completely Endophytic Renal Tumors Urology. 2021 08; 154:315-319. . View in PubMed
  • Magnetic Resonance Imaging-Targeted and Systematic Biopsy for Detection of Grade Progression in Patients on Active Surveillance for Prostate Cancer J Urol. 2021 05; 205(5):1352-1360. . View in PubMed
  • Reply by Authors J Urol. 2021 05; 205(5):1359-1360. . View in PubMed
  • Changes in Magnetic Resonance Imaging Using the Prostate Cancer Radiologic Estimation of Change in Sequential Evaluation Criteria to Detect Prostate Cancer Progression for Men on Active Surveillance Eur Urol Oncol. 2021 04; 4(2):227-234. . View in PubMed
  • ‘Case of the Month’ from the National Cancer Institute, Bethesda, MD, USA: investigating genetic aberrations in a patient with high-risk prostate cancer BJU Int. 2021 02; 127(2):171-174. . View in PubMed
  • A Focus on Focal Therapy for Prostate Cancer JAMA Surg. 2021 09 01; 156(9):881-882. . View in PubMed
  • Comparison of cross-sectional imaging techniques for the detection of prostate cancer lymph node metastasis: a critical review Transl Androl Urol. 2020 Jun; 9(3):1415-1427. . View in PubMed
  • Salvage robotic transmesenteric off-clamp partial nephrectomy after multiple prior open kidney surgeries Urol Case Rep. 2020 May; 30:101135. . View in PubMed
  • Focal therapy for prostate cancer: recent advances and future directions Clin Adv Hematol Oncol. 2020 Feb; 18(2):116-125. . View in PubMed
  • PI-RADS® Category as a Predictor of Progression to Unfavorable Risk Prostate Cancer in Men on Active Surveillance J Urol. 2020 12; 204(6):1229-1235. . View in PubMed
  • Impact of the MyProstateScore (MPS) Test on the Clinical Decision to Undergo Prostate Biopsy: Results From a Contemporary Academic Practice Urology. 2020 11; 145:204-210. . View in PubMed
  • Combined MRI-targeted Plus Systematic Confirmatory Biopsy Improves Risk Stratification for Patients Enrolling on Active Surveillance for Prostate Cancer Urology. 2020 10; 144:164-170. . View in PubMed
  • Standardized Nomenclature and Surveillance Methodologies After Focal Therapy and Partial Gland Ablation for Localized Prostate Cancer: An International Multidisciplinary Consensus Eur Urol. 2020 09; 78(3):371-378. . View in PubMed
  • MRI-Targeted, Systematic, and Combined Biopsy for Prostate Cancer Diagnosis N Engl J Med. 2020 03 05; 382(10):917-928. . View in PubMed
  • The role of multiparametric MRI in biopsy-naive prostate cancer Nat Rev Urol. 2019 May; 16(5):276-277. . View in PubMed
  • Super active surveillance for low-risk prostate cancer | Opinion: No Int Braz J Urol. 2019 Mar-Apr; 45(2):215-219. . View in PubMed
  • Use of multiparametric magnetic resonance imaging and fusion-guided biopsies to properly select and follow African-American men on active surveillance BJU Int. 2019 11; 124(5):768-774. . View in PubMed
  • Contemporary treatments in prostate cancer focal therapy Curr Opin Oncol. 2019 05; 31(3):200-206. . View in PubMed
  • Multi-institutional Survival Analysis of Incidental Pathologic T3a Upstaging in Clinical T1 Renal Cell Carcinoma Following Partial Nephrectomy Urology. 2018 Jul; 117:95-100. . View in PubMed
  • Detailed pathologic analysis on the co-occurrence of non-seminomatous germ cell tumor subtypes in matched orchiectomy and retroperitoneal lymph node dissections Med Oncol. 2018 Jan 31; 35(3):21. . View in PubMed
  • Using Imaging to Predict Treatment Response in Genitourinary Malignancies Eur Urol Focus. 2018 12; 4(6):804-817. . View in PubMed
  • Author Reply Urology. 2018 05; 115:58. . View in PubMed
  • The Urology Applicant: An Analysis of Contemporary Urology Residency Candidates Urology. 2018 05; 115:51-58. . View in PubMed
  • Robotic-assisted Thoracoscopic Transdiaphragmatic Adrenalectomy (RATTA) for Metastatic Renal Cell Carcinoma Urology. 2017 Jul; 105:9-12. . View in PubMed
  • The Role of Transurethral Resection in Trimodal Therapy for Muscle-Invasive Bladder Cancer Bladder Cancer. 2016 Oct 27; 2(4):381-394. . View in PubMed
  • Combining disparate surgical residencies into one: lessons learned J Surg Res. 2015 Oct; 198(2):289-93. . View in PubMed
  • Modern experience with aggressive parathyroid tumors in a high-volume New England referral center J Am Coll Surg. 2015 Jun; 220(6):1054-62. . View in PubMed
  • Real-Time Super Selective Venous Sampling in Remedial Parathyroid Surgery J Am Coll Surg. 2015 Jun; 220(6):994-1000. . View in PubMed
  • Peri-operative considerations in the patient with primary immune deficiency: a review Surg Infect (Larchmt). 2014 Dec; 15(6):672-8. . View in PubMed
  • Paradigm shift in the surgical management of multigland parathyroid hyperplasia: an individualized approach JAMA Surg. 2014 Nov; 149(11):1133-7. . View in PubMed
  • First nationwide survey of US integrated 6-year cardiothoracic surgical residency program directorsJ Thorac Cardiovasc Surg. 2014 Aug; 148(2):408-15. e1. . View in PubMed
  • Nationwide survey of US integrated 6-year cardiothoracic surgical residents J Thorac Cardiovasc Surg. 2014 Aug; 148(2):401-7. . View in PubMed
  • Thyroid cancer Curr Probl Cancer. 2014 Mar-Apr; 38(2):48-74. . View in PubMed
  • Appendiceal endometriosis in a pregnant woman presenting with acute perforated appendicitis J Surg Case Rep. 2013 Dec 16; 2013(12). . View in PubMed
  • TNF, acting through inducibly expressed TNFR2, drives activation and cell cycle entry of c-Kit+ cardiac stem cells in ischemic heart disease Stem Cells. 2013 Sep; 31(9):1881-92. . View in PubMed
  • Immune therapy and ß-cell death in type 1 diabetes Diabetes. 2013 May; 62(5):1676-80. . View in PubMed
  • The effects of vitamin D repletion on endothelial function and inflammation in patients with coronary artery disease Vasc Med. 2012 Dec; 17(6):394-404. . View in PubMed
  • Adrenocortical Carcinoma: Current Therapeutic State-of-the-Art J Oncol. 2012; 2012:234726. . View in PubMed
  • Neutralizing IL-6 reduces human arterial allograft rejection by allowing emergence of CD161+ CD4+ regulatory T cells J Immunol. 2011 Dec 15; 187(12):6268-80. . View in PubMed
  • Activation of human vascular cells decreases their expression of transforming growth factor-beta Atherosclerosis. 2011 Dec; 219(2):417-24. . View in PubMed
  • Transforming growth factor beta expression by human vascular cells inhibits interferon gamma production and arterial media injury by alloreactive memory T cells Am J Transplant. 2011 Nov; 11(11):2332-41. . View in PubMed
  • IFN-gamma primes intact human coronary arteries and cultured coronary smooth muscle cells to double-stranded RNA- and self-RNA-induced inflammatory responses by upregulating TLR3 and melanoma differentiation-associated gene 5 J Immunol. 2010 Jul 15; 185(2):1283-94. . View in PubMed